# US 8,278,416 B1 · Spider silk proteins and methods for producing spider silk proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,416 B1
- Document ID: US8278416B1
- Status: Granted
- Kind: B1
- Application number: 13/441,118
- Filed: 2012-04-06
- Published: 2012-10-18
- Granted: 2012-10-02
- Earliest claimed: 2005-12-30
- Assignees: Spiber Technologies AB
- Inventors: Jan Johansson; Göran Hjälm; Margareta Stark; Anna Rising; Stefan Grip; Wilhelm Engström; My Hedhammar
- Web page: https://patentgrep.com/patent/US8278416B1

## CPC

- C07K 14/43518: {from spiders}
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- D01F 4/00: Monocomponent artificial filaments or the like of proteins; Manufacture thereof
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- D01F: CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS

## Abstract

The invention provides an isolated major ampullate spidroin protein, which consists of from 150 to 420 amino acid residues and is defined by the formula REP-CT. REP is a repetitive, N-terminally derived protein fragment having from 80 to 300 amino acid residues. CT is a C-terminally derived protein fragment having from 70 to 120 amino acid residues. The invention further provides an isolated fusion protein consisting of a first protein fragment, which is a major ampullate spidroin protein, and a second protein fragment comprising a fusion partner and a cleavage agent recognition site. The first protein fragment is coupled via said cleavage agent recognition site to the fusion partner. The invention also provides a method of producing a major ampullate spidroin protein and polymers thereof.

## Claims

### Claim 1

An isolated major ampullate spidroin protein comprising the amino acid sequence as set forth in one of SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19 or SEQ ID NO: 20.

### Claim 2 (depends on 1)

An isolated fusion protein comprising the protein according to claim 1 and a protein fragment comprising a fusion partner and a cleavage agent recognition site; wherein the protein is coupled via said cleavage agent recognition site to said fusion partner.

### Claim 3 (depends on 1)

A polymer of the major ampullate spidroin protein according to claim 1.

### Claim 4 (depends on 1)

A composition comprising the isolated protein according to claim 1, wherein the content of lipopolysaccharide (LPS) and other pyrogens is 1 EU/mg of isolated protein or lower.

### Claim 5 (depends on 2)

A method of producing a soluble fusion protein as defined in claim 2, comprising the steps of:
(i) expressing a nucleic acid molecule which encodes the fusion protein according to claim 2 in a suitable host; and
(ii) isolating the soluble fusion protein obtained in step (i), optionally involving removal of lipopolysaccharide (LPS) and other pyrogens.

### Claim 6 (depends on 2)

A method of producing a polymer of a major ampullate spidroin protein, comprising the steps of:
(i) providing a solution of the fusion protein according to claim 2 in a liquid medium,
(ii) adding to said liquid medium a suitable cleaving agent for achieving cleavage of the fusion protein at the cleavage agent recognition site, and thereby obtaining the major ampullate spidroin protein;
(iii) allowing the major ampullate spidroin protein obtained in step (ii) to polymerize in the liquid medium; and
optionally (iv) isolating the polymer obtained in step (iii) from said liquid medium, optionally involving removal of lipopolysaccharide (LPS) and other pyrogens.

### Claim 7 (depends on 6)

The method according to claim 6 of producing a polymer of a major ampullate spidroin protein, wherein step (i) comprises:
(a) expressing a nucleic acid molecule which encodes said fusion protein in a suitable host;
(b) isolating the soluble fusion protein obtained in step (a), optionally involving removal of lipopolysaccharide (LPS) and other pyrogens; and
(c) providing a solution of said soluble fusion protein obtained in step (b) in a liquid medium.

### Claim 8 (depends on 7)

The method according to claim 7, wherein said step (iii) of allowing the major ampullate spidroin protein obtained in step (ii) to polymerize in the liquid medium, further comprises providing an interface between said liquid medium and another phase selected from the group consisting of a gas phase, a liquid phase and a solid phase, wherein said polymerizing initiates at said interface or in a region surrounding said interface.

### Claim 9 (depends on 7)

The method according to claim 7, wherein said liquid medium is an aqueous medium and said other phase is selected from the group consisting of air and water-immiscible organic solvents.
